Health Press Release – Newsletter for November 12, 2010

FDA Approves EGRIFTATM (tesamorelin for injection): First and Only Treatment for the Reduction of Excess Abdominal Fat in HIV-infected Patients With Lipodystrophy

Clinical Trials Demonstrate Reduction in Visceral Adipose Tissue and Waist Circumference

GENEVA, November 11, 2010 – Merck Serono, the pharmaceutical division of Merck KGaA,
Darmstadt, Germany, today announced that the U.S. Food and Drug
Administration (FDA) has approved EGRIFTA(TM) (tesamorelin for injection) as
the first and only treatment indicated to reduce excess abdominal fat in
HIV-infected patients with lipodystrophy … Read more »».

Saunders Solutions for Vets Professional Skills Online-course Suite Wins a Prestigious 2010 Brandon Hall Excellence in Learning Award

LONDON, November 11, 2010 – Elsevier's Vet CPD Professional Skills online courses have won a
coveted Brandon Hall award for excellence as 'Best Custom Content'. The suite
of five 'How To…' case-study courses build on the innovative e-learning
approach established by the trailblazing 'How to Achieve Effective
Compliance' course, created by Elsevier and its developers in conjunction
with veterinary … Read : Saunders Solutions for Vets Professional Skills Online-course Suite Wins a Prestigious 2010 Brandon Hall Excellence in Learning Award.